Dr Liezl Schonken, who is a Safety Physician at Panacea, has written an article about drug/device combination products and whether device vigilance or pharmacovigilance applies.
Read MoreSevda Hubanova Yoztyurk, who is a Pharmacovigilance Scientist & QPPV Office Co-ordinator at Panacea, has written an article about the safety of herbal medicinal products.
Read MoreLauren Morley, a Senior Regulatory Affairs Specialist at Panacea, looks at the evolution of application forms, from paper to electronic.
Read MoreMaria Hull discusses her time at Panacea and her experiences in pharmacovigilance.
Read MoreFrancisco Ferreira discusses his pharmacovigilance journey to becoming an EU QPPV at Panacea.
Read MoreLiezl Schonken, a Safety Physician at Panacea, discusses pharmacogenomics and how it may be implemented to prevent adverse drug reactions.
Read MoreMichelle Patton discusses her experiences of being an EU QPPV at Panacea.
Read MoreMartika Taylor, a Senior Safety Scientist at Panacea, looks at the use of Developmental Risk Management Plans (DRMPs) in Pharmacovigilance.
Read MorePart Two looks at PV specifics and also Quality, Non-clinical and Clinical issues and their interconnection with safety.
Read MoreLudmila Curi, a Panacea EU QPPV and Safety Physician, looks at the PV considerations for Biological and Biosimilar medicines in the EU.
Read More